Glaxo Smithkline Pharmaceuticals Ltd.
Click on the API name to know their properties
|Composit uses/ indication of PIOGLIT 15 :|
Diabetes mellitus type 2 in monotherapy and in combination with a sulfonylurea, metformin, or insulin.
|Composit contra indication of PIOGLIT 15 :|
Known hypersensitivity to pioglitazone, diabetes mellitus type 1 and diabetic ketoacidosis. Pregnancy, lactation (breastfeeding) and people under 18.
|Composit side effects of PIOGLIT 15 :|
Pharyngitis, oedema, headache, upper respiratory tract infection, sinusitis, anaemia, GI disturbances, weight gain, visual disturbances, dizziness, arthralgia, haematuria, impotence.
|Composit caution of PIOGLIT 15 :|
Increased risk of hypoglycaemia when used with insulin or oral hypoglycaemics. Oedema, congestive heart failure, hepatic dysfunction, jaundice, anaemia. May cause ovulation in premenopausal, anovulatory women. Monitor liver function before and during treatment. Monitor glycaemic control.